Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of Sunobinop on Craving in Alcohol Use Disorder
Sponsor: Knoa Pharma LLC
Summary
The purpose of this study is to evaluate the efficacy of sunobinop compared to placebo on alcohol craving in subjects with moderate to severe alcohol use disorder and these subjects are seeking treatment.
Official title: A Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Study to Evaluate Impact of Sunobinop (V117957) on Alcohol Craving in Subjects Diagnosed With Moderate to Severe Alcohol Use Disorder and Seeking Treatment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-01-28
Completion Date
2025-07-14
Last Updated
2026-07-07
Healthy Volunteers
No
Conditions
Interventions
Sunobinop
1 tablet taken orally at bedtime
Placebo to match sunobinop
1 tablet taken orally at bedtime
Locations (1)
Ohio Clinical Trials
Columbus, Ohio, United States